[Remote] Manager, REMS Advisor at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Understanding of and adherence to HIPAA regulations and company policies when handling Protected Health Information (PHI)
Thorough understanding of applicable regulations and industry trends related to program implementation
Ability to participate in User Acceptance Testing for REMS systems
Ability to document all customer interactions using internal databases and team reporting tools
Ability to maintain thorough understanding of applicable regulations and industry trends related to program implementation
Ability to stay current on departmental operations

Responsibilities

Facilitate education for healthcare professionals, including virtual tutorials and on-demand training
Generate, analyze, and report healthcare professional certification trends and track overdue tasks
Reach out to healthcare professionals to address compliance issues and provide solutions
Assist REMS Advisors in other territories, when feasible
Collaborate with cross-functional teams to address healthcare professionals’ inquiries
Collect and analyze healthcare professional and patient feedback on REMS program processes
Conduct regular review meetings with leadership to report on customer experience and program activities
Partner with internal stakeholders to gather insights and enhance program effectiveness
Identify and collaborate with REMS Advisor leadership, REMS Strategy and REMS IT to recommend technology enhancements
Rapidly identify, address and track stakeholder trends and complaints
Deliver feedback on REMS system improvements and analytics tracking

Skills

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free